{"nct_id":"NCT02289963","title":"Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2015-01","start_date_type":null,"primary_completion_date":"2016-04","primary_completion_date_type":"ACTUAL","completion_date":"2016-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}